OpiCalc Logo

OpiCalc

--- Clinical Tools

Logo
OpiCalc
7-Point Dermoscopy ChecklistAJCC Melanoma Staging (8th Ed)ALDEN Algorithm (Drug Causality for SJS/TEN)BWH High-Risk SCC StagingBody Surface Area (BSA)Breslow Thickness and Clark LevelDLQIEASI ScoreMSK Melanoma NomogramMelanoma RiskPASI ScorePOEM (Patient-Oriented Eczema Measure)RegiSCAR Criteria for DRESSSCORADSCORTENmPASI (Modified PASI)

Clinical Evidence and Methodology

EVIDENCE SYNTHESIS

Clinical Reference Hub

Curated insights • How it Works • Practical Pearls • Evidence Base

CLINICAL INSIGHT

When to Use

When to Use

  • Screening healthy individuals for their baseline risk of developing cutaneous melanoma.
  • Identifying patients who require closer dermatologic surveillance (e.g., total body skin exams every 6-12 months).
CLINICAL INSIGHT

How it Works

Risk Factors

  • Personal history of melanoma or non-melanoma skin cancer.
  • Family history of melanoma (first-degree relatives).
  • Presence of atypical (dysplastic) nevi.
  • High total nevus count (>50 or >100 depending on the model).
  • Phenotype: Fair skin, light eyes, red/blond hair, propensity to burn, freckling.
  • History of severe, blistering sunburns.
CLINICAL INSIGHT

Practical Pearls

Clinical Pearls

  • Atypical nevus syndrome (FAMMM) drastically increases risk, often requiring baseline cutaneous photography (mole mapping).
  • Risk calculators are purely predictive tools; they cannot rule out melanoma.
CLINICAL INSIGHT

Next Steps

Management

  • High Risk: Regular dermatologist screening, dedicated sun protection education, and patient counseling on self-skin exams.
  • Low Risk: Routine primary care screening and general sun protection advice.

Melanoma Risk

Breslow Depth: Core prognostic factor for localized cutaneous melanoma.
EVIDENCE SYNTHESIS

Clinical Reference Hub

Curated insights • How it Works • Practical Pearls • Evidence Base

CLINICAL INSIGHT

When to Use

When to Use

  • Screening healthy individuals for their baseline risk of developing cutaneous melanoma.
  • Identifying patients who require closer dermatologic surveillance (e.g., total body skin exams every 6-12 months).
CLINICAL INSIGHT

How it Works

Risk Factors

  • Personal history of melanoma or non-melanoma skin cancer.
  • Family history of melanoma (first-degree relatives).
  • Presence of atypical (dysplastic) nevi.
  • High total nevus count (>50 or >100 depending on the model).
  • Phenotype: Fair skin, light eyes, red/blond hair, propensity to burn, freckling.
  • History of severe, blistering sunburns.
CLINICAL INSIGHT

Practical Pearls

Clinical Pearls

  • Atypical nevus syndrome (FAMMM) drastically increases risk, often requiring baseline cutaneous photography (mole mapping).
  • Risk calculators are purely predictive tools; they cannot rule out melanoma.
CLINICAL INSIGHT

Next Steps

Management

  • High Risk: Regular dermatologist screening, dedicated sun protection education, and patient counseling on self-skin exams.
  • Low Risk: Routine primary care screening and general sun protection advice.